Skip to Content

Teva Pharmaceutical Industries Ltd ADR TEVA Stock Quote

| Rating as of

Morningstar‘s Stock Analysis TEVA

There is no Morningstar’s Analysis data available.

Key Statistics TEVA

Company Profile TEVA

Business Description

Based in Israel, Teva is one of the world’s largest generic drug manufacturers, with over 3,500 products marketed in over 60 countries. While a majority of its revenue is attributed to prescription generic drugs, Teva develops and markets its own branded specialty and biopharmaceutical products, primarily in the U.S. and in Europe. The company’s branded portfolio generates one fifth of total revenue and consists of patented therapies targeting central nervous system conditions (Austedo, Ajovy, Copaxone), oncology (Bendeka/Treanda), and respiratory conditions (ProAir, Qvar). While global competition has facilitated the commodification of small-molecule generic drugs, Teva’s portfolio rationalization has resulted in less overall price erosion versus peers.

Contact
124 Dvora HaNevi’a Street
Tel Aviv, 6944020, Israel
T +972 39148213
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Jun 30, 2022
Fiscal Year End Dec 31, 2022
Employees 37,537

Related News TEVA